HD-OPM Archive
Hashtags

#novartis

3 posts

Novartis Lp(a)HORIZON: pelacarsen failed to reduce heart attacks and strokes

Sep 04, 2026 · Louis Nervegna ♥ 20 · 💬 24 Lp(a)

Louis shares the first outcome-trial result for an Lp(a)-lowering drug: topline data from Novartis say pelacarsen lowered Lp(a) but did not show reduced cardiovascular risk overall. He says the result seriously questions whether Lp(a) is directly causal, noting only a press announcement is available so far.

Tsimikas on why Lp(a) HORIZON missed its endpoint despite strong Lp(a)-risk evidence

Sep 05, 2026 · Louis Nervegna ♥ 8 · 💬 6 Lp(a)

Louis shares a summary of Dr. Sam Tsimikas's comments on the pelacarsen HORIZON trial missing its primary endpoint. Evidence linking high Lp(a) to heart attack, stroke, PAD and aortic valve disease remains large, but most came from general populations before aggressive LDL lowering, and HORIZON patients were already aggressively treated.